EI
BTCY

EAM Investors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

EAM Investors’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,066
Closed -$1.15M – 412
2021
Q4 		$1.15M Buy
+48,066
New +$1.13M 0.19% 254

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return

EAM Investors's BTCY Position: Q1 2022 in Review

EAM Investors sold out of Biotricity, Inc. Common Stock (BTCY) in Q1 2022, closing a stake of 48,066 shares — an estimated $1.15M sold.

EAM Investors first reported a position in BTCY in Q4 2021 and held it in 1 quarter. The position peaked at $1.15M in Q4 2021. 32 funds tracked by Wall St. Rank hold BTCY as of Q1 2022.

  • EAM Investors reported no remaining Biotricity, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • EAM Investors sold 48,066 Biotricity, Inc. Common Stock shares in Q1 2022, an estimated $1.15M.
  • EAM Investors first reported a position in Biotricity, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • EAM Investors's Biotricity, Inc. Common Stock position peaked at $1.15M in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q1 2022.

Based on EAM Investors's 13F filing for Q1 2022, filed 13 May 2022.